These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34090039)

  • 1. Anti-melanoma effect of ruthenium(II)-diphosphine complexes containing naphthoquinone ligand.
    Rinaldi-Neto F; Ribeiro AB; Ferreira NH; Squarisi IS; Oliveira KM; Orenha RP; Parreira RLT; Batista AA; Tavares DC
    J Inorg Biochem; 2021 Sep; 222():111497. PubMed ID: 34090039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug.
    Oliveira KM; Honorato J; Demidoff FC; Schultz MS; Netto CD; Cominetti MR; Correa RS; Batista AA
    J Inorg Biochem; 2021 Jan; 214():111289. PubMed ID: 33137682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel lawsone-containing ruthenium(II) complexes: Synthesis, characterization and anticancer activity on 2D and 3D spheroid models of prostate cancer cells.
    De Grandis RA; Santos PWDSD; Oliveira KM; Machado ART; Aissa AF; Batista AA; Antunes LMG; Pavan FR
    Bioorg Chem; 2019 Apr; 85():455-468. PubMed ID: 30776556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruthenium complexes show promise when submitted to toxicological safety tests using alternative methodologies.
    Teixeira TM; Arraes IG; Abreu DC; Oliveira KM; Correa RS; Batista AA; Braunbeck T; de Paula Silveira Lacerda E
    Eur J Med Chem; 2021 Apr; 216():113262. PubMed ID: 33711764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiparasitic activities of novel ruthenium/lapachol complexes.
    Barbosa MI; Corrêa RS; de Oliveira KM; Rodrigues C; Ellena J; Nascimento OR; Rocha VP; Nonato FR; Macedo TS; Barbosa-Filho JM; Soares MB; Batista AA
    J Inorg Biochem; 2014 Jul; 136():33-9. PubMed ID: 24727183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ru(II)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer.
    Oliveira KM; Peterson EJ; Carroccia MC; Cominetti MR; Deflon VM; Farrell NP; Batista AA; Correa RS
    Dalton Trans; 2020 Nov; 49(45):16193-16203. PubMed ID: 32329497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruthenium(II) Diphosphine Complexes with Mercapto Ligands That Inhibit Topoisomerase IB and Suppress Tumor Growth In Vivo.
    da Silva MM; Ribeiro GH; de Camargo MS; Ferreira AG; Ribeiro L; Barbosa MIF; Deflon VM; Castelli S; Desideri A; Corrêa RS; Ribeiro AB; Nicolella HD; Ozelin SD; Tavares DC; Batista AA
    Inorg Chem; 2021 Sep; 60(18):14174-14189. PubMed ID: 34477373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and anti-cancer activity of bis-amino-phosphine ligand and its ruthenium(II) complexes.
    Engelbrecht Z; Roberts KE; Hussan A; Amenuvor G; Cronjé MJ; Darkwa J; Makhubela BCE; Sitole L
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127492. PubMed ID: 32791194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruthenium(II) complex with 2-mercaptothiazoline ligand induces selective cytotoxicity involving DNA damage and apoptosis in melanoma cells.
    de Melo MRS; Ribeiro AB; Fernandes G; Squarisi IS; de Melo Junqueira M; Batista AA; da Silva MM; Tavares DC
    J Biol Inorg Chem; 2024 Feb; 29(1):159-168. PubMed ID: 38182820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Ru(II)-bipyridine/phenanthroline-lapachol complexes as potential anti-cancer agents.
    De Grandis RA; Costa AR; Moraes CAF; Sampaio NZ; Cerqueira IH; Marques WG; Guedes APM; de Araujo-Neto JH; Pavan FR; Demidoff FC; Netto CD; Batista AA; Resende FA
    J Inorg Biochem; 2022 Dec; 237():112005. PubMed ID: 36155170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the cytotoxic and genotoxic potential of the carbonyl ruthenium(II) compound, ct-[RuCl(CO)(dppb)(bipy)]PF
    Carnizello AP; Alves JM; Pereira DE; Campos JCL; Barbosa MIF; Batista AA; Tavares DC
    J Appl Toxicol; 2019 Apr; 39(4):630-638. PubMed ID: 30460706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
    PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half-Sandwich Ru(
    Lenis-Rojas OA; Robalo MP; Tomaz AI; Fernandes AR; Roma-Rodrigues C; Teixeira RG; Marques F; Folgueira M; Yáñez J; Gonzalez AA; Salamini-Montemurri M; Pech-Puch D; Vázquez-García D; Torres ML; Fernández A; Fernández JJ
    Inorg Chem; 2021 Mar; 60(5):2914-2930. PubMed ID: 33570919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative activity of dmoPTA-Ru(II) complexes against human solid tumor cells.
    Ríos-Luci C; León LG; Mena-Cruz A; Pérez-Roth E; Lorenzo-Luis P; Romerosa A; Padrón JM
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4568-71. PubMed ID: 21719285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytotoxicity and in vivo zebrafish toxicity evaluation of Ru(ii)/2-mercaptopyrimidine complexes.
    Velozo-Sá VS; Pereira LR; Lima AP; Mello-Andrade F; Rezende MRM; Goveia RM; Pires WC; Silva MM; Oliveira KM; Ferreira AG; Ellena J; Deflon VM; Grisolia CK; Batista AA; Silveira-Lacerda EP
    Dalton Trans; 2019 May; 48(18):6026-6039. PubMed ID: 30724926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cis-[RuCl(BzCN)(N-N)(P-P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN=benzonitrile; N-N=2,2'-bipyridine; 1,10-phenanthroline; P-P=1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1'-(diphenylphosphino)ferrocene).
    Pereira Fde C; Lima BA; de Lima AP; Pires WC; Monteiro T; Magalhães LF; Costa W; Graminha AE; Batista AA; Ellena J; Siveira-Lacerda Ede P
    J Inorg Biochem; 2015 Aug; 149():91-101. PubMed ID: 25873134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Half-Sandwich Ruthenium(II) (N^N) Complex: Inducing Immunogenic Melanoma Cell Death in Vitro and in Vivo.
    Xu Z; Xu M; Wu X; Guo S; Tian Z; Zhu D; Yang J; Fu J; Li X; Song G; Liu Z; Song X
    ChemMedChem; 2023 Aug; 18(16):e202300131. PubMed ID: 37226330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-cancer effect of series of strained photoactivatable Ru(II) polypyridyl complexes on non-small-cell lung cancer and triple negative breast cancer cells.
    Fayad C; Audi H; Khnayzer RS; Daher CF
    J Biol Inorg Chem; 2021 Feb; 26(1):43-55. PubMed ID: 33221954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.